公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2012 | Persistent hepatitis B viral replication in a FVB/N mouse model: Impact of host and viral factors | Chen S.-H.; Wu H.-L.; JIA-HORNG KAO ; Hwang L.-H. | PLoS ONE | 32 | 16 | |
1994 | Possible role of high-titer maternal viremia in perinatal transmission of hepatitis c virus | HO-HSIUNG LIN ; JIA-HORNG KAO ; HONG-YUAN HSU ; YEN-HSUAN NI ; Shiou-Hwei Yeh ; Hwang L.-H.; MEI-HWEI CHANG ; Hwang S.-C.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Infectious Diseases | 180 | 140 | |
1995 | Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C | PEI-MING YANG ; Hwang L.-H.; Lai M.-Y.; Huang W.-L.; Chu Y.-D.; Chi W.-K.; BOR-LUEN CHIANG ; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN | Clinical and Experimental Immunology | 8 | 7 | |
1997 | Regression of established mouse leukemia by GM-CSF-Transduced tumor vaccine: Implications for cytotoxic T lymphocyte responses and tumor burdens | Hsieh C.-L.; Pang V.-F.; DING-SHINN CHEN ; Hwang L.-H. | Human Gene Therapy | |||
1999 | Regression of orthotopic brain tumors by cytokine-assisted tumor vaccines primed in the brain | SHENG-HONG TSENG ; Hsieh C.-L.; Lin S.-M.; Hwang L.-H. | Cancer Gene Therapy | 15 | 14 | |
2000 | Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level | Fang S.-H.; Hwang L.-H.; Chen D.-S.; BOR-LUEN CHIANG | Journal of Hepatology | 94 | 84 | |
2001 | Ribavirin enhances interferon-γ levels in patients with chronic hepatitis C treated with interferon-α | Fang S.-H.; Lai M.-Y.; Hwang L.-H.; PEI-MING YANG ; PEI-JER CHEN ; BOR-LUEN CHIANG ; DING-SHINN CHEN | Journal of Biomedical Science | 22 | 18 | |
2007 | Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-α against hepatitis C virus | Liu W.-L.; Su W.-C.; Cheng C.-W.; Hwang L.-H.; Wang C.-C.; Chen H.-L.; DING-SHINN CHEN ; Lai M.-Y. | Journal of Infectious Diseases | 32 | 29 | |
1996 | Serum hepatitis C virus titers in the progression of type C chronic liver disease with special emphasis on patients with type 1b infection | JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; Hwang L.-H.; DING-SHINN CHEN | Journal of Clinical Gastroenterology | 7 | 7 | |
2012 | Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors | Liao Z.-K.; Tsai K.-C.; Wang H.-T.; SHENG-HONG TSENG ; Deng W.-P.; WEN-SHIANG CHEN ; Hwang L.-H. | Cancer Gene Therapy | 34 | 26 | |
2013 | Stimuli-responsive HA-PEI nanoparticles encapsulating endostatin plasmid for stem cell gene therapy | Yeh P.-H.; JUI-SHENG SUN ; Wu H.-C.; Hwang L.-H.; Wang T.-W. | RSC Advances | 21 | 20 | |
2009 | Structure-based discovery of triphenylmethane derivatives as inhibitors of hepatitis C virus helicase | Chen C.-S.; Chiou C.-T.; Chen G.S.; Chen S.-C.; Hu C.-Y.; Chi W.-K.; Chu Y.-D.; Hwang L.-H.; PEI-JER CHEN ; Chen D.-S.; Liaw S.-H.; Chern J.-W. | Journal of Medicinal Chemistry | 53 | 50 | |
2001 | Structure-based mutational analysis of the hepatitis C virus NS3 helicase | Tai C.-L.; Pan W.-C.; Liaw S.-H.; Yang U.-C.; Hwang L.-H.; DING-SHINN CHEN | Journal of Virology | 66 | 62 | |
2002 | T-cell antigenic determinants within hepatitis C virus nonstructural protein 3 and cytokine production profiles in hepatitis C | Pan C.-H.; PEI-MING YANG ; Hwang L.-H.; Kao S.-F.; PEI-JER CHEN ; BOR-LUEN CHIANG ; DING-SHINN CHEN | Journal of Viral Hepatitis | 1 | 1 | |
1992 | Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: Putative serological marker for acute viral infection | PEI-JER CHEN ; JIN-TOWN WANG ; Hwang L.-H.; Yang Y.-H.; Hsieh C.-L.; JIA-HORNG KAO ; JIN-CHUAN SHEU ; Lai M.-Y.; Wang T.-H.; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 61 | 59 |